BWA Heads Into Q3 Preview With Shorts Still Elevated
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
BorgWarner reports again on August 5, just days after its July 30 Q2 print, with the short positioning that rebuilt so sharply ahead of that release still largely intact — and options traders back near defensive highs.
Short interest has barely moved since the July 24 rebuild. Shorts jumped from roughly 6.6 million shares around July 22 to over 9 million by July 24, pushing SI to 4.2% of the free float, and that position has held. The most recent reading is 4.16% of float — down only marginally from the peak. That makes the rebuild deliberate rather than reactive: the July 30 print came and went (the stock gained around 2.5% on the day), yet shorts did not cover meaningfully. Borrow costs remain subdued at 0.45%, and availability is extraordinarily loose at over 6,000% — the lending pool is barely touched — confirming there is no forced short dynamic. Bears are choosing to stay.
Options positioning is the second consistent signal. The put/call ratio has eased only slightly from its near-52-week highs seen ahead of the July 30 print, now at 0.70 against a 20-day average of 0.64 — about 0.85 standard deviations elevated. The PCR peaked at 0.72 (the 52-week high) in the days before the Q2 release. It has not collapsed in the wake of the positive price reaction, which suggests options traders are treating the August 5 event as a fresh test rather than rolling off hedges. The stock itself has drifted lower — off about 1% on the week and 4% over the past month, closing at $63.74 — while peer LEA dropped over 10% on the week and ADNT fell nearly 4%, putting BWA in better relative shape across the auto-parts complex.
The analyst community has been broadly constructive. Multiple firms raised targets between May and July — Barclays lifted its target to $83 (Overweight) in early July, and UBS upgraded to Buy with a $95 target in June. The consensus mean target stands near $77, roughly 20% above the current price. Morgan Stanley is the outlier, holding at Equal-Weight with a $67 target, reflecting caution on the pace of BorgWarner's EV transition execution and the risk that margins disappoint at the segment level. The forward EPS momentum score ranks in the 83rd percentile, a genuine bull case; bears counter that insider selling has been persistent — the CEO sold nearly $2 million of stock in May, and VPs have been trimming steadily since — signalling executives are not expecting a sharp re-rating.
The August 5 print is therefore a test of whether the Q2 beat was a turning point or a one-quarter reprieve: specifically, whether BorgWarner's electrification revenue trajectory and margin guidance can give the still-elevated short position a reason to finally cover.
Stocks in this article
See the live data behind this article on ORTEX.
Open BWA on ORTEX →How this article was generated
- Generated
- 2 Aug 2026, 04:07
- Data as of
- 2 Aug 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.